Nivien Therapeutics
www.washingtonpost.comNivien Therapeutics developed the first LATS1/2 kinase inhibitors. https://www.washingtonpost.com/national/health-science/heres-what-happened-when-i-tried-to-develop-a-new-drug-for-a-deadly-cancer/2019/01/11/
Read more
Nivien Therapeutics developed the first LATS1/2 kinase inhibitors. https://www.washingtonpost.com/national/health-science/heres-what-happened-when-i-tried-to-develop-a-new-drug-for-a-deadly-cancer/2019/01/11/
Read more
Country
State
Massachusetts
City (Headquarters)
Boston
Industry
Employees
1-10
Founded
2016
Estimated Revenue
$250,000,000 to $500,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Founder
Email ****** @****.comPhone (***) ****-****
Technologies
(268)
Reach decision makers at Nivien Therapeutics
Free credits every month!
Nivien Therapeutics FAQ
Boston, United States
Biotechnology Research
